CRISPR AND CAS GENE MARKET ANALYSIS

Leading Companies

• By end user, the market is segmented into biotechnology and pharmaceutical companies, academic & government research institutes, and contract research organizations. Out of which,  biotechnology and pharmaceutical companies is expected to dominate the market over the forecast period, and this is attributed to the increasing research and development activities by biotechnology companies.

Global Crispr and Cas Gene Market - Cross Sectional Analysis:

Key players are focusing on inorganics strategies, such as collaborations, for the development of products is expected to drive the market growth over the forecast period.

Global Crispr and Cas Gene Market: Key Developments

• On November 2, 2020, PerkinElmer, a company headquarted in U.S. acquired cell engineering specialist, Horizon Discovery Group for approximately US$ 383 million. Horizon Discovery Group is based in the U.K. about 400 employees worldwide with offices in the U.S. and Japan. They specialize in genetic base editing technologies for living cell models by way of CRISPR reagents, in addition to gene modulation products using RNA interference methods.
• On April 6, 2020, GlaxoSmithKline plc, a pharmaceutical company, and Vir Biotechnology, Inc., a biotechnology company, headquartered in California, U.S. announced a  agreement to enter into a collaboration to research and develop solutions for coronaviruses, including SARS-CoV-2, the virus that causes COVID-19. The companies will leverage GSK’s expertise in functional genomics and combine their capabilities in CRISPR screening and artificial intelligence to find anti-coronavirus compounds that target cellular host genes.